Protease Nexin 1 Is Expressed in the Human Placenta

Summary

Protease nexin 1 (PN1), a serine protease inhibitor that inactivates thrombin, urokinase, and plasmin, is produced abundantly in cultures of human fibroblasts and rat and human glioma cells. The major sites of PN1 synthesis in vivo and the specific physiological function(s) of this serpin are unknown. Using Northern blot analysis and a full-length PN1 cDNA probe we demonstrated the presence of PN1 mRNA in human term placentas. In situ hybridization of placental tissue with a PN1 riboprobe showed that PN1 mRNA is present throughout the placenta and is also abundant in the placental membranes. Immunohistochemical analysis with an anti-PN1 antibody showed co-localization of PN1 and its mRNA within the placenta.

• References

• 1 Baker JB, McGrogan M, Simonsen CC, Scott RW, Gronke RS, Honeyman A. Protease nexin I. Structure and potential functions. In: The Pharmacology and Toxicology of Proteins. Winkelhake JL, Holcenberg JS. (eds). Alan R. Liss Inc.; New York: 1987
• 2 Scott RW, Bergman BL, Bajpai A, Hersh RT, Rodriguez H, Jones BN, Barreda C, Watts S, Baker JB. Protease nexin: properties and a modified purification procedure. J Biol Chem 1985; 260: 7029-7034
• 3 Kruithof EKO. Plasminogen activator inhibitors. Enzyme 1988; 40: 113-121
• 4 Cunningham DD, Gurwitz D. Proteolytic regulation of neurite outgrowth from neuroblastoma cells by thrombin and protease nexin-1. J Cell Biochem 1989; 39: 55-64
• 5 Bergman BL, Scott RW, Bajpai A, Watts S, Baker JB. Inhibition of tumor-cell-mediated extracellular matrix destruction by a fibroblast proteinase inhibitor protease nexin I. Proc Natl Acad Sci USA 1986; 83: 996-1000
• 6 Rao JS, Kahler BS, Baker JB, Festoff BW. Protease nexin I, a serpin, inhibits plasminogen-dependent degradation of muscle extracellular matrix. Muscle and Nerve 1989; 12: 640-646
• 7 Hébert CA, Baker JB. Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: Colocalization of cell surface urokinase with vinculin. J Cell Biol 1988; 106: 1241-1247
• 8 Pöänen J, Hedman K, Nielsen LS, Danø K, Vaheri A. Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts. J Cell Biol 1988; 106: 87-95
• 9 Cajot JF, Bamat J, Bergonzelli GE, Kruithof EKO, Medcalf RL, Testuz J, Sordat B. Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells. Proc Natl Acad Sci USA 1990; 87: 6939-6943
• 10 Danø K, Andreason PA, Grødahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 1985; 44: 139-266
• 11 Blasi F, Vassalli JD, Danø K. Urokinase-type plasminogen activator: Proenzyme, receptor, and inhibitors. J Cell Biol 1987; 104: 801-804
• 12 Saksela O, Rifkin DB. Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol 1988; 4: 93-126
• 13 Strickland S, Reich E, Sherman MI. Plasminogen activator in early embryogenesis: Enzyme production by trophoblast and parietal endoderm. Cell 1976; 9: 231-240
• 14 Hébert CA. personal communication.
• 15 Blood CH, Zetter BR. Tumor interactions with the vasculature: Angiogenesis and tumor metastasis. Biochim Biophys Acta 1990; 1032: 89-118
• 16 Pyke C, Kristensen P, Ralfkiaer E, Eriksen J, Danø K. The plasminogen activation system in human colon cancer: Messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma. Cancer Res 1991; 51: 4067-4071
• 17 Pöllänen J, Stephens RW, Vaheri A. Directed plasminogen activation at the surface of normal and malignant cells. Adv Cancer Res 1991; 57: 273-328
• 18 Farell DH, Wagner SL, Yuan RH, Cunningham DD. Localization of protease nexin-1 on the fibroblast extracellular matrix. J Cell Physiol 1988; 134: 179-188
• 19 Gloor S, Odink K, Guenther J, Nick H, Monard D. A glia-derived neurite promoting factor with protease inhibitory activity belongs to the protease nexins. Cell 1986; 47: 687-693
• 20 Baker JB, Low DA, Simmer RL, Cunningham DD. Protease nexin: A cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell 1980; 21: 37-45
• 21 McGrogan M, Kennedy J, Li MP, Hsu C, Scott RW, Simonsen CC, Baker JB. Molecular cloning and expression of two forms of human protease nexin I. Biotechnol 1988; 6: 172-177
• 22 Rao JS, Baker JB, Morantz RA, Kimler B, Evans R, Festoff BW. Serpin inhibitors of urokinase and thrombin in normal rat brain and the 9 L brain tumor: Evidence for elevated expression of protease nexin I-like inhibitor and a novel sodium dodecyl sulfate-activated tumor antithrombin. Cancer Res 1990; 50: 5039-5044
• 23 Gronke RS, Knauer DJ, Veeraraghavan S, Baker JB. A form of protease nexin I is expressed on the platelet surface during platelet activation. Blood 1989; 73: 472-478
• 24 Han JH, Stratowa C, Rutter WJ. Isolation of full-length putative rat lysophospholipase cDNA using improved methods for mRNA isolation and cDNA cloning. Biochemistry 1987; 26: 1617-1625
• 26 Willingham MC, Pastan I. An Atlas of Immunofluorescence in Cultured Cells. Academic Press; Orlando, CA: 1985
• 27 Yagel S, Parhar RS, Jeffrey JJ, Lala PK. Normal nonmetastatic human trophoblast cells share in vitro invasive properties of malignant cells. J Cell Physiol 1988; 136: 455-462
• 28 Åstedt B, Hägerstrand I, Lecander I. Cellular localisation in placenta of placental type plasminogen activator inhibitor. Thromb Haemostas 1986; 56: 63-65
• 29 Feinberg RF, Kao L-C, Haimowitz JE, Queenan JT, Wun T-C, Strauss JF, Kliman HJ. Plasminogen activator inhibitor types 1 and 2 in human trophoblasts. Lab Invest 1989; 61: 20-26
• 30 Laug WE, Aerbersold R, Jong A, Rideout W, Bergman BL, Baker J. Isolation of multiple types of plasminogen activator inhibitors from vascular smooth muscle cells. Thromb Haemostas 1989; 61: 517-521